InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Alan Ezekowitz
26 Jun 2026
Director
Sell
18,000
$3.65
$65.61K
Robert J Gould
2 Feb 2026
Director
Sell
15,000
$10.72
$160.86K
Robert J Gould
2 Jan 2026
Director
Sell
15,000
$11.87
$178.09K
Curtis Gale Oltmans
15 Dec 2025
Chief Legal Officer
Sell
3,452
$12.92
$44.60K
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
91,722
$14.98
$1.37M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
2,706,397
$14.28
$38.65M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
1,377,020
$13.33
$18.36M
Robert J Gould
19 Nov 2025
Director
Sell
15,000
$11.03
$165.50K
Show all 14 transactions →

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 0
History held since 18 Jul 2019